{"Ticker": "MTD", "Company": "Mettler Toledo", "Sector": "Health Care", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Underweight to Neutral", "Target_Change": "$1100 to $1350"}, {"Date": "2022-11-08", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Sell to Neutral", "Target_Change": "$1120 to $1355"}, {"Date": "2022-09-06", "Rating": "Upgrade", "Organization": "Stifel", "Rating_Change": "Hold to Buy", "Target_Change": "$1500"}, {"Date": "2022-07-20", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$1237"}, {"Date": "2022-04-25", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Overweight", "Target_Change": ""}, {"Date": "2022-03-10", "Rating": "Downgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Sell", "Target_Change": "$1240"}, {"Date": "2021-04-07", "Rating": "Resumed", "Organization": "Robert W. Baird", "Rating_Change": "Neutral", "Target_Change": "$1160"}, {"Date": "2021-01-04", "Rating": "Upgrade", "Organization": "Evercore ISI", "Rating_Change": "Underperform to In-line", "Target_Change": "$1150"}, {"Date": "2020-12-17", "Rating": "Upgrade", "Organization": "Cleveland Research", "Rating_Change": "Neutral to Buy", "Target_Change": ""}, {"Date": "2020-12-02", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$1140"}, {"Date": "2020-10-07", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Neutral to Sell", "Target_Change": ""}, {"Date": "2020-09-28", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Underweight", "Target_Change": "$880"}, {"Date": "2020-04-09", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "In-line to Underperform", "Target_Change": ""}, {"Date": "2020-04-02", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Underperform", "Target_Change": "$586"}, {"Date": "2020-03-26", "Rating": "Upgrade", "Organization": "Barclays", "Rating_Change": "Underweight to Equal Weight", "Target_Change": "$680"}, {"Date": "2020-01-08", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$815"}, {"Date": "2020-01-07", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$800"}, {"Date": "2020-01-02", "Rating": "Upgrade", "Organization": "Evercore ISI", "Rating_Change": "Underperform to In-line", "Target_Change": "$680 to $790"}, {"Date": "2019-11-15", "Rating": "Initiated", "Organization": "Stifel", "Rating_Change": "Hold", "Target_Change": ""}, {"Date": "2019-10-17", "Rating": "Reiterated", "Organization": "BofA/Merrill", "Rating_Change": "Neutral", "Target_Change": "$830 to $720"}, {"Date": "2019-07-23", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Sell to Neutral", "Target_Change": "$660 to $760"}, {"Date": "2019-07-15", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Equal Weight to Underweight", "Target_Change": "$680"}, {"Date": "2019-05-30", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": ""}, {"Date": "2019-04-16", "Rating": "Reiterated", "Organization": "BofA/Merrill", "Rating_Change": "Neutral", "Target_Change": "$725 to $755"}, {"Date": "2019-01-03", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "In-line to Underperform", "Target_Change": ""}, {"Date": "2019-01-03", "Rating": "Downgrade", "Organization": "BofA/Merrill", "Rating_Change": "Buy to Neutral", "Target_Change": ""}]}